These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 25200734)

  • 1. B cell subsets are activated and produce cytokines during early phases of Francisella tularensis LVS infection.
    Plzakova L; Kubelkova K; Krocova Z; Zarybnicka L; Sinkorova Z; Macela A
    Microb Pathog; 2014 Oct; 75():49-58. PubMed ID: 25200734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycogen synthase kinase-3beta (GSK3beta) inhibition suppresses the inflammatory response to Francisella infection and protects against tularemia in mice.
    Zhang P; Katz J; Michalek SM
    Mol Immunol; 2009 Feb; 46(4):677-87. PubMed ID: 18929413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung CD4-CD8- double-negative T cells are prominent producers of IL-17A and IFN-gamma during primary respiratory murine infection with Francisella tularensis live vaccine strain.
    Cowley SC; Meierovics AI; Frelinger JA; Iwakura Y; Elkins KL
    J Immunol; 2010 May; 184(10):5791-801. PubMed ID: 20393138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early activation of NK cells after lung infection with the intracellular bacterium, Francisella tularensis LVS.
    López MC; Duckett NS; Baron SD; Metzger DW
    Cell Immunol; 2004; 232(1-2):75-85. PubMed ID: 15922718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Entry of Francisella tularensis into Murine B Cells: The Role of B Cell Receptors and Complement Receptors.
    Plzakova L; Krocova Z; Kubelkova K; Macela A
    PLoS One; 2015; 10(7):e0132571. PubMed ID: 26161475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide-independent killing of Francisella tularensis by IFN-gamma-stimulated murine alveolar macrophages.
    Polsinelli T; Meltzer MS; Fortier AH
    J Immunol; 1994 Aug; 153(3):1238-45. PubMed ID: 8027551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific antibodies protect gamma-irradiated mice against Francisella tularensis infection.
    Kubelkova K; Krocova Z; Balonova L; Pejchal J; Stulik J; Macela A
    Microb Pathog; 2012; 53(5-6):259-68. PubMed ID: 22841607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of the live attenuated Francisella tularensis vaccine (LVS) in a murine model of disease.
    Green M; Choules G; Rogers D; Titball RW
    Vaccine; 2005 Apr; 23(20):2680-6. PubMed ID: 15780452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine-Mediated Mechanisms Controlling Replication of
    Eneslätt K; Golovliov I; Rydén P; Sjöstedt A
    Front Cell Infect Microbiol; 2018; 8():27. PubMed ID: 29468144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Francisella tularensis LVS grown in macrophages has reduced ability to stimulate the secretion of inflammatory cytokines by macrophages in vitro.
    Loegering DJ; Drake JR; Banas JA; McNealy TL; Mc Arthur DG; Webster LM; Lennartz MR
    Microb Pathog; 2006 Dec; 41(6):218-25. PubMed ID: 16996713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of anti-LPS IgM by B1a B cells depends on IL-1β and is protective against lung infection with Francisella tularensis LVS.
    del Barrio L; Sahoo M; Lantier L; Reynolds JM; Ceballos-Olvera I; Re F
    PLoS Pathog; 2015 Mar; 11(3):e1004706. PubMed ID: 25768794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine response in Balb/c mice infected with Francisella tularensis LVS and the Pohang isolate.
    Kim EJ; Park SH; Choi YS; Shim SK; Park MY; Park MS; Hwang KJ
    J Vet Sci; 2008 Sep; 9(3):309-15. PubMed ID: 18716452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Francisella tularensis LVS initially activates but subsequently down-regulates intracellular signaling and cytokine secretion in mouse monocytic and human peripheral blood mononuclear cells.
    Telepnev M; Golovliov I; Sjöstedt A
    Microb Pathog; 2005; 38(5-6):239-47. PubMed ID: 15925273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple T cell subsets control Francisella tularensis LVS intracellular growth without stimulation through macrophage interferon gamma receptors.
    Cowley SC; Elkins KL
    J Exp Med; 2003 Aug; 198(3):379-89. PubMed ID: 12885873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed presence of alternatively activated macrophages during a Francisella tularensis infection.
    D'Elia RV; Laws TR; Núñez A; Taylor C; Clark GC
    Microb Pathog; 2015 Jan; 78():37-42. PubMed ID: 25284816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility to secondary Francisella tularensis live vaccine strain infection in B-cell-deficient mice is associated with neutrophilia but not with defects in specific T-cell-mediated immunity.
    Bosio CM; Elkins KL
    Infect Immun; 2001 Jan; 69(1):194-203. PubMed ID: 11119506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of primary human alveolar epithelial cells in host defense against Francisella tularensis infection.
    Gentry M; Taormina J; Pyles RB; Yeager L; Kirtley M; Popov VL; Klimpel G; Eaves-Pyles T
    Infect Immun; 2007 Aug; 75(8):3969-78. PubMed ID: 17502386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid local expression of interleukin-12, tumor necrosis factor alpha, and gamma interferon after cutaneous Francisella tularensis infection in tularemia-immune mice.
    Stenmark S; Sunnemark D; Bucht A; Sjöstedt A
    Infect Immun; 1999 Apr; 67(4):1789-97. PubMed ID: 10085019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Francisella tularensis LVS infection of macrophages results in a reduced inflammatory response: evaluation of a therapeutic strategy for intracellular bacteria.
    D'Elia R; Jenner DC; Laws TR; Stokes MG; Jackson MC; Essex-Lopresti AE; Atkins HS
    FEMS Immunol Med Microbiol; 2011 Aug; 62(3):348-61. PubMed ID: 21569124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of a Fixed Bacterial Immunogen to Fc Receptors Reverses the Anti-Inflammatory Properties of the Gram-Negative Bacterium, Francisella tularensis, during the Early Stages of Infection.
    Babadjanova Z; Wiedinger K; Gosselin EJ; Bitsaktsis C
    PLoS One; 2015; 10(6):e0129981. PubMed ID: 26114641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.